The weight loss drug market may reach 95billionwithinfiveyears.ThenewgenerationofeffectiveweightlossdrugshasgeneratedbillionsofdollarsforindustryleadersEliLilly(LLY−0.9695 billion within five years.The new generation of effective weight loss drugs has generated billions of dollars for industry leaders Eli Lilly (LLY -0.96%) and Novo Nordisk (NVO 1.39%), and opened the door for companies such as Viking Therapeutics and Amgen that are working on rival new candidates.The growth of this healthcare niche looks to be far from over: While the weight loss drug segment is expected to be worth 95billionwithinfiveyears.ThenewgenerationofeffectiveweightlossdrugshasgeneratedbillionsofdollarsforindustryleadersEliLilly(LLY−0.9628 billion this year, Goldman Sachs Research predi ...
礼来(US:LLY) The Motley Fool·2025-09-16 15:15